| Zugriffe | |
|---|---|
| Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 255 |
| Oktober 2024 | November 2024 | Dezember 2024 | Januar 2025 | Februar 2025 | März 2025 | April 2025 | |
|---|---|---|---|---|---|---|---|
| Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 6 | 0 | 2 | 5 | 3 | 3 | 1 |
| Zugriffe | |
|---|---|
| art_3A10.1186_2Fs13195-016-0189-7.pdf | 183 |
